The Acorda Therapeutics, Inc., ACOR has Gain (↑) on Monday, December 02, 2019 the stock price is settled at $1.61 after buying and selling hours while rehearsed a difference of 0.62 percent. The stock has a fifty two-week low of $8.05 percent while its fifty two-weeks high are $-92.32 percent.
The total market cap for the stock is $84.62M while it has a PE ratio of 0. Active investor focuses on important indicators rehearsed a difference in session that includes where the Acorda Therapeutics, Inc..
Each buying and selling session display one-of-a-kind actions and patterns about Acorda Therapeutics, Inc. (ACOR) stock. Presently we watched the different factors that seen on close of last session. Toward the day’s end, it’s only a stock’s exhibition that issues.
Acorda Therapeutics, Inc.’s overall performance:
The performance of the stock during the last 7.00 days was -14.36 percent,
during the last one-month price index is -2.42 percent while over the 3.00 months is -45.24 percent.
Its 6.00 months performance has been -82.59 percent while for the beyond 52.00 weeks is -92 percent.
We have additionally seen that the stock is exchanging -31.36 percent away from the 50-day MA and -77.73 percent of the 20-day MA.
How much shares are traded?
The stock traded hands with 2042196 numbers of shares contrast to its normal every day volume of 1.67M shares.
What amount of stock is unpredictable?
Beta factor was seen at 1.19. Beta estimates the hazard of the security. High beta >1 means implies higher dangerous and low beta <1 shows low peril. The stock remained 8.83 percent erratic for the ongoing week and 12.63 percent for the last month.
Acorda Therapeutics, Inc. has a P/S and P/B values of 0.4 and 0.27 respectively. Its P/Cash valued at 0.33. The ACOR has PEG of 0. Technical indicators do not lead us to assume the stock will see more gains anytime soon.
Analyst’s mean target amount for the company is 5.58 while analysts mean suggestion is 3.1.